Aurora-A phosphorylates hnRNPK and disrupts its interaction with p53

Katayama, 2003, The Aurora kinases: role in cell transformation and tumorigenesis, Cancer Metastasis Rev., 22, 451, 10.1023/A:1023789416385 Carmena, 2009, Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins, Curr. Opin. Cell Biol., 21, 796, 10.1016/j.ceb.2009.09.008 Bischoff, 1998, A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers, Embo J., 17, 3052, 10.1093/emboj/17.11.3052 Gritsko, 2003, Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer, Clin. Cancer Res., 9, 1420 Ju, 2006, Functional polymorphism 57Val>Ile of aurora kinase A associated with increased risk of gastric cancer progression, Cancer Lett., 242, 273, 10.1016/j.canlet.2005.11.015 Li, 2003, Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer, Clin. Cancer Res., 9, 991 Park, 2008, Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection, J. Natl. Cancer Inst., 100, 1401, 10.1093/jnci/djn304 Sen, 1997, A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines, Oncogene, 14, 2195, 10.1038/sj.onc.1201065 Tong, 2004, Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma, Clin. Cancer Res., 10, 7304, 10.1158/1078-0432.CCR-04-0806 Zhou, 1998, Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation, Nat. Genet., 20, 189, 10.1038/2496 Liu, 2004, Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215, J. Biol. Chem., 279, 52175, 10.1074/jbc.M406802200 Katayama, 2004, Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53, Nat. Genet., 36, 55, 10.1038/ng1279 Wu, 2005, Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening, J. Biol. Chem., 280, 9013, 10.1074/jbc.M411068200 Moumen, 2005, HnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage, Cell, 123, 1065, 10.1016/j.cell.2005.09.032 Bomsztyk, 2004, HnRNP K: one protein multiple processes, Bioessays, 26, 629, 10.1002/bies.20048 Ostrowski, 2002, Heterogeneous nuclear ribonucleoprotein K protein associates with multiple mitochondrial transcripts within the organelle, J. Biol. Chem., 277, 6303, 10.1074/jbc.M110267200 Michael, 1997, The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein, Embo J., 16, 3587, 10.1093/emboj/16.12.3587 Ostareck-Lederer, 2002, C-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs, Mol. Cell Biol., 22, 4535, 10.1128/MCB.22.13.4535-4543.2002 Sataranatarajan, 2008, PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K, Cell Signal, 20, 969, 10.1016/j.cellsig.2008.01.016 Schullery, 1999, Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein, J. Biol. Chem., 274, 15101, 10.1074/jbc.274.21.15101 Chen, 2009, Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells, Oncogene, 28, 1904, 10.1038/onc.2009.55 Habelhah, 2001, ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation, Nat. Cell Biol., 3, 325, 10.1038/35060131 Chen, 2008, Arginine methylation of hnRNP K enhances p53 transcriptional activity, FEBS Lett., 582, 1761, 10.1016/j.febslet.2008.04.051 Ostareck-Lederer, 2006, Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src, J. Biol. Chem., 281, 11115, 10.1074/jbc.M513053200 Hosokawa, 2010, Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS–PAGE, Mol. Cell Proteomics, 9, 1133, 10.1074/mcp.M900578-MCP200 Huang, 2008, Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia, Blood, 111, 2854, 10.1182/blood-2007-07-099325 Yano, 2005, Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation, J. Biol. Chem., 280, 12690, 10.1074/jbc.M411119200 Bomsztyk, 1997, Diverse molecular interactions of the hnRNP K protein, FEBS Lett., 403, 113, 10.1016/S0014-5793(97)00041-0 Krystyniak, 2006, Inhibition of Aurora A in response to DNA damage, Oncogene, 25, 338, 10.1038/sj.onc.1209056 Daub, 2008, Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle, Mol. Cell, 31, 438, 10.1016/j.molcel.2008.07.007 Yu, 2007, Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra, J. Proteome Res., 6, 4150, 10.1021/pr070152u Ohashi, 2006, Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies, Oncogene, 25, 7691, 10.1038/sj.onc.1209754 Mukhopadhyay, 2009, Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation, Cancer Res., 69, 2210, 10.1158/0008-5472.CAN-08-2308